Langhao Medical Technology (Hunan) Co., Ltd. announced that it has signed an agreement and issued common shares for a total gross proceeds of CNY 4 million in September, 2022. The transaction included participation from new investor, Tibet Duo Rui Pharmaceutical Co.,Ltd. for 25% stake. Out of CNY 4 million, CNY 3.3333 million is in registered capital and the rest in capital reserve.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.47 CNY | +0.93% | -0.70% | -30.75% |
1st Jan change | Capi. | |
---|---|---|
-30.75% | 201M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Langhao Medical Technology Co., Ltd. announced that it has received CNY 4 million in funding from Tibet Duo Rui Pharmaceutical Co.,Ltd.